What is Inspira Technologies Oxy BHN Ltd?
, a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel.
IINN · Verdict
Moderate reward · elevated risk
IINN stands out on balance sheet and valuation, but watch the cash flow signal.
Based on 88% data coverage
IINN · Verdict
Current ratio 2.02
P/E 10.7×
Weak vs peers
Weak vs peers
-339% return on equity
Earnings -91.3% CAGR
Model-based scoring. For information only — not financial advice.
, a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 24.22M.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.